Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review
Avatar

Treatment Strategies in MDS and ALL: Removing Bad Humor & Targeting Aberrant Signaling

By Indy Hematology Review FEATURING Richard Stone
By Indy Hematology Review FEATURING Richard Stone
31 views
April 22, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
2024
28:40
Indy Hematology Review

Management of Long-Term Survivors of Hematologic Malignancies in 2024

Feat. S. Garofalo
23:06
Indy Hematology Review

Understanding and Addressing the Challenges in CML in 2024

Feat. R. Larson
34:34
Indy Hematology Review

Current & Emerging Therapies for AML and MDS

Feat. R. Komrokji
20:39
Indy Hematology Review

Emerging and Current Treatment of Waldenstrom’s Macroglobulinemia

Feat. S. Treon
33:17
Indy Hematology Review

Managing Benign Hematology Disorders

Feat. C. Kessler
24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
28:20
Indy Hematology Review

Managing Newly Diagnosed MM in 2024

Feat. S. Usmani
28:10
Indy Hematology Review

2024 Updates on Understanding & Managing Immune Effector Cell To…

Feat. D. Reeves
21:56
Indy Hematology Review

Emerging and Current Treatment for Hodgkin Lymphoma in 2024

Feat. S. Ansell
27:47
Indy Hematology Review

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Feat. S. Smith
25:23
Indy Hematology Review

When Not to Watch and Wait: Emerging Strategies in the Treatment of …

Feat. M. Williams
22:47
Indy Hematology Review

CLL: Evaluating and Therapeutic Approaches for the Management of the…

Feat. J. Woyach
22:38
Indy Hematology Review

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Feat. T. Phillips
24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
25:12
Indy Hematology Review

Beyond Pain: Improving the Outcomes of SCD With Therapeutics and Cel…

Feat. A. Shet
20:17
Indy Hematology Review

Managing Amyloidosis in 2024: Diagnosis and Treatment

Feat. M. Gertz
19:00
Indy Hematology Review

Waldenstrom’s Macroglobulinemia: Approaching the Newly Diagnosed and…

Feat. S. Treon
24:04
Indy Hematology Review

Treatment Strategies in MDS and ALL: Removing Bad Humor & Target…

Feat. R. Stone
30:08
Indy Hematology Review

Classical Hematology: Managing Disorders of Bleeding and Clotting

Feat. C. Kessler
17:01
Indy Hematology Review

Current, Emerging, and Targeted Therapies for the Treatment of R/R A…

Feat. R. Komrokji
45:10
Indy Hematology Review

Recent Advances in Classical Hematology

Feat. R. Brodsky
31:53
Indy Hematology Review

HSCT in 2024: What Every Hematologist Needs to Know

Feat. R. Childs
22:50
Indy Hematology Review

Emerging and Cellular Therapeutic Options for MM: Understanding Your…

Feat. S. Usmani
23:11
Indy Hematology Review

Treatment Considerations for Initial Therapy of CLL

Feat. P. Hillmen
20:43
Indy Hematology Review

Controversies in the Management of CML in 2024

Feat. R. Larson
17:51
Indy Hematology Review

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Feat. H. Erba
24:48
Indy Hematology Review

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Feat. R. Rampal
17:52
Indy Hematology Review

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Feat. K. Anderson
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray